We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Levetiracetam-Induced Diffuse Interstitial Lung Disease.
- Authors
Newsome, Scott D.; Xue, Lanny Y.; Jennings, Timothy; Castaneda, Glenn Y.
- Abstract
The authors report the first case of levetiracetam-induced diffuse interstitial lung disease. The patient is a 9-year-old girl who was admitted to the pediatric intensive care unit for aspiration pneumonia. She has a history of epilepsy, cerebral palsy, mental retardation, asthma, and repeated hospitalizations for presumed aspiration pneumonia, which resolved with conventional medical treatment. She has been on low-dose levetiracetam for her epilepsy over the past 2 years, and the dosage was increased just prior to this admission. However, this time, with conventional treatment, the patient's aspiration pneumonia did not improve, which led to a lung biopsy. The biopsy demonstrated a diffuse interstitial process of relatively recent onset, with features consistent with diffuse lung disease. Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis, The patient improved clinically after the discontinuation of levetiracetam and with the treatment of steroids.
- Subjects
ANTICONVULSANTS; INTERSTITIAL lung diseases in children; PULMONARY fibrosis; CHILDHOOD epilepsy; CEREBRAL palsy; INTELLECTUAL disabilities; ASTHMA in children; LUNG biopsy; STEROID drugs; THERAPEUTICS
- Publication
Journal of Child Neurology, 2007, Vol 22, Issue 5, p628
- ISSN
0883-0738
- Publication type
Article
- DOI
10.1177/0883073807302602